A cash infusion from Nestle and an uptick in online consumer sales has buoyed ChromaDex as executives say the brand is on course to be in plus EBITDA territory by the end of fiscal 2022.
ChromaDex is in line to receive another $23 million of investment, including from a fund associated with Facebook CEO Mark Zuckerberg, via private placement of stock.